WO2008015380A3 - Protéine membranaire intégrale - Google Patents

Protéine membranaire intégrale Download PDF

Info

Publication number
WO2008015380A3
WO2008015380A3 PCT/GB2007/002703 GB2007002703W WO2008015380A3 WO 2008015380 A3 WO2008015380 A3 WO 2008015380A3 GB 2007002703 W GB2007002703 W GB 2007002703W WO 2008015380 A3 WO2008015380 A3 WO 2008015380A3
Authority
WO
WIPO (PCT)
Prior art keywords
claudin
emp
pmp
family
membrane protein
Prior art date
Application number
PCT/GB2007/002703
Other languages
English (en)
Other versions
WO2008015380A8 (fr
WO2008015380A2 (fr
Inventor
Richard Joseph Fagan
Christine Power
Original Assignee
Ares Trading Sa
Richard Joseph Fagan
Christine Power
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa, Richard Joseph Fagan, Christine Power filed Critical Ares Trading Sa
Publication of WO2008015380A2 publication Critical patent/WO2008015380A2/fr
Publication of WO2008015380A3 publication Critical patent/WO2008015380A3/fr
Publication of WO2008015380A8 publication Critical patent/WO2008015380A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une nouvelle protéine, nommée INSP219, identifiée dans le présent document comme une protéine, notamment comme une molécule de type PMP-22/EMP/MP20/Claudin, et l'utilisation de cette protéine et de la séquence d'acides nucléiques du gène codant pour le diagnostic, la prévention et le traitement de maladies.
PCT/GB2007/002703 2006-08-01 2007-07-17 Protéine membranaire intégrale WO2008015380A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0615287A GB0615287D0 (en) 2006-08-01 2006-08-01 Integral membrane protein
GB0615287.0 2006-08-01

Publications (3)

Publication Number Publication Date
WO2008015380A2 WO2008015380A2 (fr) 2008-02-07
WO2008015380A3 true WO2008015380A3 (fr) 2008-03-20
WO2008015380A8 WO2008015380A8 (fr) 2009-07-16

Family

ID=37006569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/002703 WO2008015380A2 (fr) 2006-08-01 2007-07-17 Protéine membranaire intégrale

Country Status (2)

Country Link
GB (1) GB0615287D0 (fr)
WO (1) WO2008015380A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2561886A1 (fr) 2011-08-23 2013-02-27 Forschungsverbund Berlin e.V. Adjuvant de peptide pour analgésie périphérique améliorée
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
CN113813222A (zh) 2014-08-28 2021-12-21 通用医疗公司 治疗神经疾病的组合物和方法
SG10201913504XA (en) 2016-02-26 2020-03-30 Massachusetts Gen Hospital Medical ice slurry production and delivery systems and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018412A1 (fr) * 2000-08-28 2002-03-07 Human Genome Sciences, Inc. 17 protéines humaines sécrétées
WO2003054152A2 (fr) * 2001-12-10 2003-07-03 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018412A1 (fr) * 2000-08-28 2002-03-07 Human Genome Sciences, Inc. 17 protéines humaines sécrétées
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003054152A2 (fr) * 2001-12-10 2003-07-03 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 15 June 2006 (2006-06-15), "Therapeutic protein HAJCL25, SEQ ID 1978.", XP002463237, retrieved from EBI accession no. GSP:AEH08769 Database accession no. AEH08769 *
DATABASE Geneseq [online] 15 June 2006 (2006-06-15), "Therapeutic protein HAJCL25, SEQ ID 1979.", XP002463236, retrieved from EBI accession no. GSP:AEH08770 Database accession no. AEH08770 *
DATABASE Geneseq [online] 29 January 2004 (2004-01-29), "Novel protein (useful for identifying genetic disorders) #521.", XP002463239, retrieved from EBI accession no. GSP:ADE08366 Database accession no. ADE08366 *
DATABASE Geneseq [online] 29 January 2004 (2004-01-29), "Novel protein (useful for identifying genetic disorders) #522.", XP002463238, retrieved from EBI accession no. GSP:ADE08367 Database accession no. ADE08367 *
DATABASE Geneseq [online] 5 June 2002 (2002-06-05), "Human secreted protein sequence #24.", XP002463242, retrieved from EBI accession no. GSP:AAU91104 Database accession no. AAU91104 *
DATABASE Geneseq [online] 5 June 2002 (2002-06-05), "Human secreted protein sequence #25.", XP002463240, retrieved from EBI accession no. GSP:AAU91105 Database accession no. AAU91105 *
DATABASE Geneseq [online] 5 June 2002 (2002-06-05), "Human secreted protein sequence #53.", XP002463241, retrieved from EBI accession no. GSP:AAU91133 Database accession no. AAU91133 *
DATABASE UniProt [online] 1 March 2003 (2003-03-01), "12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130077N03 product:hypothetical protein, full insert sequence.", XP002463235, retrieved from EBI accession no. UNIPROT:Q8BNC6 Database accession no. Q8BNC6 *
DATABASE UniProt [online] 16 August 2004 (2004-08-16), "Zgc:92710.", XP002463244, retrieved from EBI accession no. UNIPROT:Q6DGZ4 Database accession no. Q6DGZ4 *
DATABASE UniProt [online] 30 May 2006 (2006-05-30), "Novel protein (Zgc:92710).", XP002463243, retrieved from EBI accession no. UNIPROT:Q1L8F4 Database accession no. Q1L8F4 *

Also Published As

Publication number Publication date
WO2008015380A8 (fr) 2009-07-16
WO2008015380A2 (fr) 2008-02-07
GB0615287D0 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
WO2008065372A3 (fr) Polypeptides d'érythropoïétine modifiés et utilisation de ceux-ci dans des traitements
WO2007007173A3 (fr) Nouveaux anticorps anti-madcam
WO2006128041A3 (fr) Compositions et procedes destines a traiter ou a prevenir un neoplasme chimiomoresistant
NO20052956D0 (no) Defensinprotiner
WO2008015380A3 (fr) Protéine membranaire intégrale
WO2008095622A3 (fr) Luciférase secrétée mluc7 et son utilisation
WO2006046073A3 (fr) Proteine du type c1q
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2006016172A3 (fr) Glycoproteine de surface
WO2007084488A3 (fr) Adam10 et ses utilisations dans l'infection
WO2007049065A3 (fr) Proteine contenant des domaines vwfa, collagene et kunitz
WO2007068913A3 (fr) Protéines contenant le domaine SRCR-B
WO2008001045A8 (fr) Membres de la famille de protéines connue sous le nom de famille des glycosides hydrolases 31
WO2008003925A3 (fr) Protéine du complément
WO2007144492A3 (fr) Peptides a activite anti-proliferative
WO2007039254A3 (fr) Utilisation de proteines de fusion pour la prevention et le traitement de maladies resultant d'une ischemie
WO2004009633A8 (fr) Recepteur de serotonine
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2004056983A3 (fr) Proteines de metalloprotease
WO2006051333A3 (fr) Proteines contenant des motifs repetes riches en leucine (lrr)
WO2007049062A3 (fr) Protéines contenant des domaines vwfa
WO2006122650A3 (fr) Photoproteine isolee aqdecay et utilisation
WO2004081170A3 (fr) Proteine de type recepteur de la progestine
WO2004016654A8 (fr) Proteine du type il-8
WO2004024762A3 (fr) Proteine de type il-8

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07766272

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07766272

Country of ref document: EP

Kind code of ref document: A2